title: The use of rivaroxaban in patients with antiphospholipid syndrome: A series of 12 cases.
authors: Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland.
authors: Maksim
authors: M
authors: Son
authors: Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland; John Paul II Hospital, Cracow, Poland.
authors: Ewa
authors: E
authors: Wypasek
authors: Department of Medicine, Jagiellonian University Medical College, Cracow, Poland.
authors: Magdalena
authors: M
authors: Celinska-Lowenhoff
authors: Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland; John Paul II Hospital, Cracow, Poland. Electronic address: mmundas@cyf-kr.edu.pl.
authors: Anetta
authors: A
authors: Undas
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000276:immunology; D000069552:Rivaroxaban / Q000627:therapeutic use*; D055502:Secondary Prevention; D054556:Venous Thromboembolism / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D000069552:Rivaroxaban